Plain-English translation of NCT07290803 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atopic Dermatitis research guide →This is a real-world tracking study for people aged 12 and older with atopic dermatitis (eczema) who are starting or switching to a systemic treatment—medications like biologics or oral JAK inhibitors that work throughout your whole body. Researchers will follow your treatment journey for up to 5 years, collecting information about how well the medication works for you, any side effects, and how it affects your daily life. The study is happening across 10 countries and will help doctors better understand what works for different patients.
Doctors want to understand how these newer, stronger eczema treatments perform in everyday real-world settings—not just in controlled clinical trials. By tracking patients like you over several years, researchers can learn which treatments work best for different people, what side effects to watch for, and how to improve care for others with eczema in the future.
You likely qualify if…
You likely don't qualify if…
You will continue taking the eczema treatment your doctor prescribes as part of your normal care—this study does not assign you to a specific medication. Instead, researchers will regularly collect information from your medical records about how your treatment is working, any side effects you experience, and how your eczema is affecting your skin and quality of life. Over 5 years, you will have follow-up appointments where doctors gather this information, and you may answer questions about your treatment experience and symptoms.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
United States